Academic: Insomnia Across the Lifespan: Evaluation and Evidence-Based Treatment
Insomnia affects up to 30–48% of Americans and carries significant costs to individual health, workplace productivity, and public safety. In this session, expert clinician Dr. Wendy L. Wright, DNP, APRN equips Nurse Practitioners with a comprehensive, guideline-aligned approach to diagnosing and managing insomnia across the lifespan, from pediatric presentations to older adults.
Learners will apply DSM-5-TR diagnostic criteria, conduct a targeted clinical work-up, and evaluate nonpharmacologic strategies alongside the full spectrum of pharmacologic options: OTC agents, melatonin receptor agonists, orexin receptor antagonists, Z-drugs, and benzodiazepines. Special attention is given to drug safety, Beers Criteria considerations, herb-drug interactions, and population-specific prescribing to optimize sleep outcomes and daytime functioning.